WELLCARE ACT MASTERY EXAM
FLASHCARDS AND HIGH-YIELD TOPICS 2026
◉ Final 2025 plan and benefit information may be discussed with
beneficiaries on or before September 30, 2024. Answer: FALSE
◉ Effective 2026, key provisions of the Inflation Reduction Act
include Medicare's ability to negotiate directly with drug
manufacturers to lower the price of some of the costliest single-
source brand-name Medicare Part B and Part D drugs. Answer:
TRUE
◉ Which Low-Income Subsidy (LIS) category is assigned to
members whose costs are fully subsidized and receive the most
assistance? Answer: Three
◉ All Traditional Medicare Advantage Prescription Drug (MAPD)
plans will offer $0 copay for most Part D preventive vaccines
regardless of network pharmacy used by members. Answer: TRUE
◉ For 2025, Wellcare preferred networks include Walgreens, CVS,
and some grocery chains. Answer: TRUE
, ◉ Agents must meet all required contracting, training, and
certification requirements annually to be eligible to sell Wellcare's
Medicare products. Answer: TRUE
◉ Disciplinary actions stemming from the result of a compliance
allegation are always progressive. Answer: FALSE
◉ As part of Centene's Ethics and Compliance program, Centene
requires all agents to review and agree to its Business Ethics and
Code of Conduct Policy. Answer: TRUE
◉ When enrolling a Dual Eligible Special Needs Plan (D-SNP)
beneficiary, be sure to verify plan enrollment eligibility and that the
Medicare Savings Program (MSP) level is eligible for the requested
plan. Answer: TRUE
◉ When prospective Wellcare members check online for the status
of their submitted application, which element is optional? Answer:
Confirmation Number
◉ The Third-Party Marketing Organization (TPMO) disclaimer must
be used by any TPMO that sells plans on behalf of more than one
Medicare Advantage (MA) plan provider. The disclaimer must be:
(Select all that apply.) Answer: - Included in any marketing
materials, including print materials and television advertisements
developed, used, or distributed by the TPMO.
FLASHCARDS AND HIGH-YIELD TOPICS 2026
◉ Final 2025 plan and benefit information may be discussed with
beneficiaries on or before September 30, 2024. Answer: FALSE
◉ Effective 2026, key provisions of the Inflation Reduction Act
include Medicare's ability to negotiate directly with drug
manufacturers to lower the price of some of the costliest single-
source brand-name Medicare Part B and Part D drugs. Answer:
TRUE
◉ Which Low-Income Subsidy (LIS) category is assigned to
members whose costs are fully subsidized and receive the most
assistance? Answer: Three
◉ All Traditional Medicare Advantage Prescription Drug (MAPD)
plans will offer $0 copay for most Part D preventive vaccines
regardless of network pharmacy used by members. Answer: TRUE
◉ For 2025, Wellcare preferred networks include Walgreens, CVS,
and some grocery chains. Answer: TRUE
, ◉ Agents must meet all required contracting, training, and
certification requirements annually to be eligible to sell Wellcare's
Medicare products. Answer: TRUE
◉ Disciplinary actions stemming from the result of a compliance
allegation are always progressive. Answer: FALSE
◉ As part of Centene's Ethics and Compliance program, Centene
requires all agents to review and agree to its Business Ethics and
Code of Conduct Policy. Answer: TRUE
◉ When enrolling a Dual Eligible Special Needs Plan (D-SNP)
beneficiary, be sure to verify plan enrollment eligibility and that the
Medicare Savings Program (MSP) level is eligible for the requested
plan. Answer: TRUE
◉ When prospective Wellcare members check online for the status
of their submitted application, which element is optional? Answer:
Confirmation Number
◉ The Third-Party Marketing Organization (TPMO) disclaimer must
be used by any TPMO that sells plans on behalf of more than one
Medicare Advantage (MA) plan provider. The disclaimer must be:
(Select all that apply.) Answer: - Included in any marketing
materials, including print materials and television advertisements
developed, used, or distributed by the TPMO.
